DNA Damage-Free iPS Cells Exhibit Potential to Yield Competent Cardiomyocytes

DNA damage accrued in iPS-derived cardiomyocytes (iPS-CMs) during in vitro culture practices lessens their clinical potentials for therapy. We determined whether DNA damage-free iPSCs (DdF-iPS) can...